Immix Biopharma (IMMX) Cash from Investing Activities (2021 - 2026)
Quarterly results put Cash from Investing Activities at -$4.8 million for Q1 2026, down 6989.98% from a year ago — trailing twelve months through Mar 2026 was -$11.9 million (down 1166.26% YoY), and the annual figure for FY2025 was -$7.2 million, down 512.54%.
Immix Biopharma has reported Cash from Investing Activities over the past 5 years, most recently at -$4.8 million for Q1 2026.
- Cash from Investing Activities reached -$4.8 million in Q1 2026 per IMMX's latest filing, up from -$6.6 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$13177.0 in Q4 2023 and bottomed at -$6.6 million in Q4 2025.
- Median Cash from Investing Activities over the past 4 years was -$286727.5 (2024), compared with a mean of -$1.3 million.
- The largest annual shift saw Cash from Investing Activities soared 77.57% in 2025 before it crashed 6989.98% in 2026.
- Over 4 years, Cash from Investing Activities stood at -$13177.0 in 2023, then plummeted by 3748.76% to -$507151.0 in 2024, then tumbled by 1210.46% to -$6.6 million in 2025, then rose by 27.76% to -$4.8 million in 2026.
- Business Quant data shows Cash from Investing Activities for IMMX at -$4.8 million in Q1 2026, -$6.6 million in Q4 2025, and -$372456.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -428.90 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | -4.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.80 Mn |
| Mar 31, 2026 | -4.80 Mn |
| Dec 31, 2025 | -6.65 Mn |
| Dec 31, 2025 | -6.65 Mn |
| Sep 30, 2025 | -372,456.00 |
| Sep 30, 2025 | -372,456.00 |
| Jun 30, 2025 | -127,630.00 |
| Jun 30, 2025 | -127,630.00 |
| Mar 31, 2025 | -67,713.00 |
| Mar 31, 2025 | -67,713.00 |
| Dec 31, 2024 | -507,151.00 |
| Dec 31, 2024 | -507,151.00 |
| Sep 30, 2024 | -271,542.00 |
| Sep 30, 2024 | -271,542.00 |
| Jun 30, 2024 | -97,074.00 |
| Jun 30, 2024 | -97,074.00 |
| Mar 31, 2024 | -301,913.00 |
| Mar 31, 2024 | -301,913.00 |
| Dec 31, 2023 | -13,177.00 |
| Dec 31, 2023 | -13,177.00 |
| Mar 31, 2021 | -802.00 |
| Mar 31, 2021 | -802.00 |